Trial intelligence / Profile preview

Immune and transcriptomic responses to TIV versus ATIV in healthy young children

2012-002443-26Phase 2Completed

Sponsor
University of Oxford
Start
Jul 2012
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 2, randomised, open-label trial of Fluzone Trivalent, influenza vaccine and cell-based trivalent influenza virus vaccine in influenza (2 arms), sponsored by University of Oxford. Started Jul 2012; status: completed.

02

Drugs

Fluzone Trivalentinfluenza vaccinecell-based trivalent influenza virus vaccine
03

Conditions

influenza

Beyond the preview

Go deeper on 2012-002443-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-002443-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call